3

FORM 3 SUBMISSION

Company: NewAmsterdam Pharma Co N.V.
Filed: December 29, 2023
Period of Report: December 29, 2023
Accession Number: 0000899243-23-020705

View Document ↗ View on SEC.gov ↗